Disruptive: Wyss Institute Podcast

How can programmable nanomaterials
lead to medical breakthroughs?

In this episode of Disruptive, Wyss Core Faculty Member Dave Mooney discusses programmable nanomaterials approaches to fighting disease, including a cancer vaccine currently in a clinical trial


Read More

From the Newsroom

    • apnea

      Clinical trial substantiates Wyss Institute’s apnea prevention technology

      Wyss scientists and clinicians from Beth Israel Deaconess Medical Center and University of Massachusetts Medical School provide clinical evidence that the technology benefits breathing stability in preterm infants

      Read More


  • gene drive

    New clues for multifunctional materials

    Wyss Institute and MIT researchers show how a single biomineral has been evolved in the shell of a sea-dwelling chiton to perform both protective and visual functions, which could help scientists identify general design rules for still unavailable artificial multifunctional materials

    Read More


Media Coverage




  • Self-Improving Microvascular Materials

    December 8, 2015

    Aaron Esser-Kahn, Assistant Professor from University of California, Irvine, will discuss his initial efforts to develop a simple synthetic morphogenetic system that repatterns microvascular materials using dynamic covalent chemistry of siloxanes. He will demonstrate that his synthetic system improves the function of materials by altering microstructure

    Read more Other events









We've won a Webby Award!

Wyss Institute is proud to announce our win in the 2012
Webby Awards in the Science category.